Axentis Pharma

Contact
axentispharma.com
+41448177817

Axentis Pharma AG

Leuholz 14
8855 Wangen
Switzerland
+41448177817
axentispharma.com
Contact
Profile Products News
Contact

About Axentis Pharma

Axentis Pharma AG is a Swiss biotech company. The company owns proprietary technology used in the treatment of diseases, the etiology of which is misrouted or misfolded proteins, for example, cystic fibrosis, nephrogenic diabetes insipidus, hypercholesterolemia and others. Axentis is managed by a team of experienced entrepreneurs.

Read more about Axentis Pharma
Facts about Axentis Pharma
  • Focus : Manufacturer
  • Industry : Pharma

Product portfolio of Axentis Pharma

Product portfolio

Show all

News about Axentis Pharma

Axentis Pharma

14-Sep-2009 | business & finance

OctoPlus signs service contract with Axentis Pharma

OctoPlus N.V. announced that it has signed a pharmaceutical development and manufacturing contract with a new client, Axentis Pharma AG. The undisclosed ...

Read news
Axentis Pharma

06-May-2009 | research and development

Orphan drug designation for treatment against lung infections by Axentis Pharma AG

Axentis Pharma announced that the Office of Orphan Products Development of the US Food and Drug Administration (FDA) has granted the orphan drug ...

Read news
Axentis Pharma

27-Jun-2008 | business & finance

Mucoviscidosis Therapy Gets Closer

Axentis Pharma takes over patents and continues development of innovative platform technology

Read news
Axentis Pharma

21-Dec-2007 | business & finance

Cystic Fibrosis: License agreement boosts development of therapy against lung infections

Axentis Pharma AG (Switzerland) and aRigen Pharmaceuticals, Inc. (Japan) announced the signature of a license agreement for the development of therapy ...

Read news
Show more news about Axentis Pharma

Here you will find Axentis Pharma AG